Literature DB >> 19819765

Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry.

Max Scherer1, Carsten Gnewuch, Gerd Schmitz, Gerhard Liebisch.   

Abstract

Beside their role as lipid solubilizers, bile acids (BAs) are increasingly appreciated as signaling factors. As ligands of G-protein coupled receptors and nuclear hormone receptors BAs control their own metabolism and act on lipid and energy metabolism. To study BA function in detail, it is necessary to use methods for their quantification covering the structural diversity of this group. Here we present a simple, sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the analysis of bile acid profiles in human plasma/serum. Protein precipitation was performed in the presence of stable-isotope labeled internal standards. In contrast to previous LC-MS/MS methods, we used a reversed-phase C18 column with 1.8microm particles and a gradient elution at basic pH. This allows base line separation of 18 bile acid species (free and conjugated) within 6.5min run time and a high sensitivity in negative ion mode with limits of detection below 10nmol/L. Quantification was achieved by standard addition and calibration lines were linear in the tested range up to 28micromol/L. Validation was performed according to FDA guidelines and overall imprecision was below 11% CV for all species. The developed LC-MS/MS method for bile acid quantification is characterized by simple sample preparation, baseline separation of isobaric species, a short analysis time and provides a valuable tool for both, routine diagnostics and the evaluation of BAs as diagnostic biomarkers in large clinical studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819765     DOI: 10.1016/j.jchromb.2009.09.038

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  39 in total

1.  Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals.

Authors:  Olga Renner; Simone Harsch; Silke Matysik; Dieter Lütjohann; Gerd Schmitz; Eduard F Stange
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice.

Authors:  Xiaolun Sun; Kathryn Winglee; Raad Z Gharaibeh; Josee Gauthier; Zhen He; Prabhanshu Tripathi; Dorina Avram; Steven Bruner; Anthony Fodor; Christian Jobin
Journal:  Gastroenterology       Date:  2018-02-01       Impact factor: 22.682

3.  Quantitative analysis of 3alpha,6alpha,24-trihydroxy-24,24-di(trifluoromethyl)-5beta-cholane, a potent synthetic steroidal liver X receptor agonist in plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Jian Guo; Dacheng Peng; Qing Dai; Shutsung Liao; Brian J Wright; Richard B van Breemen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-01       Impact factor: 3.205

4.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Lipid Res       Date:  2012-07-19       Impact factor: 5.922

5.  Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder.

Authors:  Matthieu Ruiz; Alexanne Cuillerier; Caroline Daneault; Sonia Deschênes; Isabelle Robillard Frayne; Bertrand Bouchard; Anik Forest; Julie Thompson Legault; Frederic M Vaz; John D Rioux; Yan Burelle; Christine Des Rosiers
Journal:  JCI Insight       Date:  2019-07-25

6.  Evaluating the structural complexity of isomeric bile acids with ion mobility spectrometry.

Authors:  Xueyun Zheng; Francesca B Smith; Noor A Aly; Jingwei Cai; Richard D Smith; Andrew D Patterson; Erin S Baker
Journal:  Anal Bioanal Chem       Date:  2019-05-16       Impact factor: 4.142

7.  Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242.

Authors:  Christopher J Martoni; Alain Labbé; Jorge G Ganopolsky; Satya Prakash; Mitchell L Jones
Journal:  Gut Microbes       Date:  2015

8.  Gene silencing of non-obese diabetic receptor family (NLRP3) protects against the sepsis-induced hyper-bile acidaemia in a rat model.

Authors:  Y Wu; J Ren; B Zhou; C Ding; J Chen; G Wang; G Gu; X Wu; S Liu; D Hu; J Li
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

9.  Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases.

Authors:  Ibrahim Choucair; Ina Nemet; Lin Li; Margaret A Cole; Sarah M Skye; Jennifer D Kirsop; Michael A Fischbach; Valentin Gogonea; J Mark Brown; W H Wilson Tang; Stanley L Hazen
Journal:  J Lipid Res       Date:  2019-12-09       Impact factor: 5.922

10.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.